You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies

Article metrics

Article menu
XML
Immune cell therapies and immune cell engineering
Original research
Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies

 

Online download statistics by month:

Online download statistics by month: July 2021 to September 2025

AbstractFullPdf
Jul 2021355356164
Aug 202112312332
Sep 2021919145
Oct 2021979725
Nov 2021848518
Dec 2021575714
Jan 2022535418
Feb 2022464922
Mar 2022535326
Apr 2022404318
May 2022454527
Jun 2022444526
Jul 2022424329
Aug 2022484927
Sep 2022555542
Oct 2022505218
Nov 202237388
Dec 202229298
Jan 2023262616
Feb 2023444529
Mar 2023232348
Apr 2023252811
May 2023232314
Jun 2023232312
Jul 2023141414
Aug 2023363613
Sep 2023252516
Oct 2023242421
Nov 2023323214
Dec 202325258
Jan 2024313211
Feb 2024323220
Mar 2024505070
Apr 2024414425
May 2024313317
Jun 2024363520
Jul 2024474921
Aug 202433298
Sep 2024485060
Oct 2024484826
Nov 2024323412
Dec 2024545820
Jan 2025282818
Feb 2025565629
Mar 2025343436
Apr 2025595921
May 2025333320
Jun 2025242418
Jul 2025110
Sep 2025110
Total238824181235